Wasem, Jürgen; Wong, J.b.; Siebert, U.; Manns, M.p.; McHutchison, J.g.; Sroczynski, G.; Ravens-Sieberer, U.; Rossol, S.; Ling, M.h.; Albrecht, J.K. for the German Hepatitis C Model Group; the International Hepatitis Interventional Therapy Group:
Cost-effectiveness of ribavirin and pegylated inerferon alfa-2b for initial treatment of chronic hepatitis C.
2001
In: Hepatology, Jg. 44 (2001), Heft 2, S. 691A
Artikel/Aufsatz in Zeitschrift2001Wirtschaftswissenschaften
Titel:
Cost-effectiveness of ribavirin and pegylated inerferon alfa-2b for initial treatment of chronic hepatitis C.
Autor(in):
Wasem, JürgenLSF; Wong, J.b.; Siebert, U.; Manns, M.p.; McHutchison, J.g.; Sroczynski, G.; Ravens-Sieberer, U.; Rossol, S.; Ling, M.h.; Albrecht, J.K. for the German Hepatitis C Model Group; the International Hepatitis Interventional Therapy Group
Erscheinungsjahr
2001